There's been a lot of news coming out of Chicago this week from the annual meeting of the American Association for Cancer Research (AACR). Two announcements concerning prostate cancer research are especially worth broadcasting. An Ann Arbor pathologist, Arul M. Chinnaiyan, of the University of Michigan Comprehensive Cancer Center, will be leading a "dream team" of specialists from 5 of the top cancer research institutes in the world in a $10M, 3-year research project titled “Precision Therapy for Advanced Prostate Cancer.” The funding comes from AACR partner, Stand Up To Cancer (SU2C), and the Prostate Cancer Foundation (PCF). Heading up the team with Dr. Chinnaiyan is Dr. Charles L. Sawyers of Memorial Sloan-Kettering Cancer Center in New York.
Tags: University of Michigan, Midwest, Bioresearch, cancer research, nanotechnology, genome research, genomic medicine, 2012, Ann Arbor, BioResearch Product Faire Event, Funding, Research Funding, Conference, MI, science event, scientific conference, science current event, scientific events, UMich, Cancer Center, science research funding
Traditionally, the only kind of conference with the steam to get a lot of people really worked up and to make headlines has been the sports variety, as in "Buffalo embarrasses Washington for critical conference win" or "Big East releases 2012 conference schedule." But a scientific conference with 1000 participants and hundreds of simulcasts by teaching hospitals, medical schools, research institutions, university life science departments, state and federal government agencies, health-oriented corporations and nonprofits across the nation? Welcome to TEDMED 2012, coming to Washington DC (and a big screen near you) this April 10-13, and generating a lot of buzz in its advance wake.